Genes in panel
Prev Next
STRs in panel
Prev Next
Regions in panel

Common deletion and duplication syndromes

Region: ISCA-37430-Gain

Chromosome 17p13.3 duplication syndrome, centromeric

Green List (high evidence)

Chromosome: 17
GRCh38 Position: 1344539-2685615
Haploinsufficiency Score:
Triplosensitivity Score: Sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype
Required percent of overlap: 80%
Variant types: CNV Gain

1 review

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Well established CNV, involving the LIS1 and/or YWHAE genes. Individuals with LIS1 duplications have brain abnormalities, including microcephaly, dysgenesis of the corpus callosum, and cerebellar atrophy, as well as neurobehavioral disorders, including delayed development, mental retardation, and attention deficit-hyperactivity disorder. Patients with duplications of YWHAE tend to have macrosomia, facial dysmorphism, and mild developmental delay.
Sources: Expert list
Created: 3 Dec 2020, 9:46 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Chromosome 17p13.3 duplication syndrome, centromeric, MIM#613215; intellectual disability

Details

ISCA ID
ISCA-37430-Gain
ISCA Region Name
Chromosome 17p13.3 duplication syndrome, centromeric
Chromosome
17
GRCh38 Coordinates
1344539-2685615
Haploinsufficiency Score
Triplosensitivity Score
Sufficient evidence suggesting dosage sensitivity is associated with clinical phenotype
Required percent of overlap
80%
Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Expert list
Phenotypes
  • Chromosome 17p13.3 duplication syndrome, centromeric, MIM#613215
  • intellectual disability
Tags
SV/CNV
Clinvar variants
Variants in
Penetrance
None
Variant types
CNV Gain

History Filter Activity

3 Dec 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Region: isca-37430-gain has been classified as Green List (High Evidence).

3 Dec 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Region: isca-37430-gain has been classified as Green List (High Evidence).

3 Dec 2020, Gel status: 1

Created, Added New Source, Added Tag, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Region: ISCA-37430-Gain was added Region: ISCA-37430-Gain was added to Common deletion and duplication syndromes. Sources: Expert list SV/CNV tags were added to Region: ISCA-37430-Gain. Mode of inheritance for Region: ISCA-37430-Gain was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for Region: ISCA-37430-Gain were set to Chromosome 17p13.3 duplication syndrome, centromeric, MIM#613215; intellectual disability Review for Region: ISCA-37430-Gain was set to GREEN